Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2026-03-13 @ 6:28 AM
Study NCT ID:
NCT00070304
Status:
COMPLETED
Last Update Posted:
2013-07-26
First Post:
2003-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
Sponsor:
Children's Oncology Group
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent/refractory childhood Hodgkin lymphoma | View |
| None | childhood lymphocyte predominant Hodgkin lymphoma | View |
| None | childhood lymphocyte depletion Hodgkin lymphoma | View |
| None | childhood nodular sclerosis Hodgkin lymphoma | View |
| None | childhood mixed cellularity Hodgkin lymphoma | View |